Artemether–lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania-Reference-Cited by-同舟云学术

Artemether–lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania

Published:2012-05-25 Issue:1 Volume:11 Page:
ISSN:1475-2875
Container-title:Malaria Journal
language:en
Short-container-title:Malar J

Author:

Färnert Anna,Ursing Johan,Tolfvenstam Thomas,Rono Josea,Karlsson Lillemor,Sparrelid Elda,Lindegårdh Niklas

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Parasitology

Link

http://link.springer.com/content/pdf/10.1186/1475-2875-11-176.pdf

Reference17 articles.

1. World Health Organization: Guidelines for the treatment of malaria. http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf ,

2. Liljander A, Wiklund L, Falk N, Kweku M, Martensson A, Felger I, Färnert A: Optimization and validation of multi-coloured capillary electrophoresis for genotyping of Plasmodium falciparum merozoite surface proteins (msp1 and 2). Malar J. 2009, 8: 78-10.1186/1475-2875-8-78.

3. Lefevre G, Looareesuwan S, Treeprasertsuk S, Krudsood S, Silachamroon U, Gathmann I, Mull R, Bakshi R: A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. AmJTrop Med Hyg. 2001, 64: 247-256.

4. Price RN, Uhlemann AC, van Vugt M, Brockman A, Hutagalung R, Nair S, Nash D, Singhasivanon P, Anderson TJ, Krishna S, White NJ, Nosten F: Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clin Infect Dis. 2006, 42: 1570-1577. 10.1086/503423.

5. Makanga M, Bassat Q, Falade CO, Premji ZG, Krudsood S, Hunt P, Walter V, Beck HP, Marrast AC, Cousin M, Rosenthal PJ: Efficacy and safety of artemether-lumefantrine in the treatment of acute, uncomplicated Plasmodium falciparum malaria: a pooled analysis. AmJTrop Med Hyg. 2011, 85: 793-804.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. THE DEVELOPMENT AND VALIDATION OF A FAST STABILITY INDICATING RP-HPLC METHOD FOR QUANTIFICATION OF LUMEFANTRINE AND ITS ORGANIC IMPURITIES USING CENTRAL COMPOSITE EXPERIMENTAL DESIGN;International Journal of Applied Pharmaceutics;2023-05-07

2. Pharmacotherapy for artemisinin-resistant malaria;Expert Opinion on Pharmacotherapy;2021-07-29

3. Efficacy of artemisinin–lumefantrine for treatment of uncomplicated malaria after more than a decade of its use in Kenya;Epidemiology and Infection;2021

4. Development of nanocarriers for innovative antimalarial combination strategies;Applications of Nanobiotechnology for Neglected Tropical Diseases;2021

5. Evidence for linkage of pfmdr1, pfcrt, and pfk13 polymorphisms to lumefantrine and mefloquine susceptibilities in a Plasmodium falciparum cross;International Journal for Parasitology: Drugs and Drug Resistance;2020-12